IL139163A - Method of predicting the ability of compounds to modulate the biological activity of receptors - Google Patents

Method of predicting the ability of compounds to modulate the biological activity of receptors

Info

Publication number
IL139163A
IL139163A IL13916399A IL13916399A IL139163A IL 139163 A IL139163 A IL 139163A IL 13916399 A IL13916399 A IL 13916399A IL 13916399 A IL13916399 A IL 13916399A IL 139163 A IL139163 A IL 139163A
Authority
IL
Israel
Prior art keywords
receptor
modulate
ability
assays
biological activity
Prior art date
Application number
IL13916399A
Other languages
English (en)
Other versions
IL139163A0 (en
Original Assignee
Univ Duke
Karobio Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke, Karobio Ab filed Critical Univ Duke
Publication of IL139163A0 publication Critical patent/IL139163A0/xx
Publication of IL139163A publication Critical patent/IL139163A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743Steroid hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Collating Specific Patterns (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13916399A 1998-04-23 1999-03-26 Method of predicting the ability of compounds to modulate the biological activity of receptors IL139163A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8275698P 1998-04-23 1998-04-23
US9965698P 1998-09-09 1998-09-09
US11534599P 1999-01-08 1999-01-08
PCT/US1999/006664 WO1999054728A2 (en) 1998-04-23 1999-03-26 Method of predicting receptor modulating activity

Publications (2)

Publication Number Publication Date
IL139163A0 IL139163A0 (en) 2001-11-25
IL139163A true IL139163A (en) 2005-09-25

Family

ID=27374331

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13916399A IL139163A (en) 1998-04-23 1999-03-26 Method of predicting the ability of compounds to modulate the biological activity of receptors

Country Status (9)

Country Link
EP (1) EP1073891B1 (de)
JP (1) JP2002512368A (de)
KR (1) KR100637955B1 (de)
AT (1) ATE335994T1 (de)
AU (1) AU769917B2 (de)
CA (1) CA2329738C (de)
DE (1) DE69932712T2 (de)
IL (1) IL139163A (de)
WO (1) WO1999054728A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660468B1 (en) 1998-10-27 2003-12-09 Board Of Trustees Of The University Of Arkansas Vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction
WO2002000716A2 (en) * 2000-06-28 2002-01-03 Bristol-Myers Squibb Company Cell lines and cell-based assays for identification of androgen receptor modulators
EP1360501A2 (de) * 2000-07-12 2003-11-12 Karo Bio USA, Inc. Verfahren zur identifizierung von konformation-empfindlichen bindenden peptiden und ihre verwendung
DE10040289A1 (de) * 2000-08-17 2002-02-28 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung und Ermittlung geeigneter Effektoren von Zielmolekülen mit Substanzbibliotheken
US6586190B2 (en) 2000-08-18 2003-07-01 Syngenta Participations Ag Parallel high throughput method and kit
WO2004035614A1 (en) * 2001-07-11 2004-04-29 Karo Bio Ab Synthetic or partially purified peptides which can bind to specific subunits of g proteins and uses thereof
AU2003205605A1 (en) * 2002-01-18 2003-07-30 Karo Bio Ab Conformation-specific, protein kinase binding peptides and related methods and products
EP1353182A3 (de) * 2002-04-12 2004-02-04 Smithkline Beecham Corporation Verfahren zur Vorhersage von Zell-basierten Assay Resultaten mit Hilfe von Bindungsprofilen
EP1637885A1 (de) * 2004-09-16 2006-03-22 Vivalis Screeningverfahren von Konformation empfindlichen bindenden Peptiden
US7842662B2 (en) 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
RU2500685C2 (ru) 2006-11-10 2013-12-10 Кара Терапеутикс, Инк Синтетические пептидные амиды
PL4054201T3 (pl) 2007-04-18 2024-08-12 Dolby International Ab Systemy kodowania
US20140072058A1 (en) 2010-03-05 2014-03-13 Thomson Licensing Coding systems
EP2480888B1 (de) 2009-09-25 2016-11-30 XOMA Technology Ltd. Screening-verfahren
WO2011083147A1 (en) 2010-01-08 2011-07-14 Cemm-Forschungsinstitut Für Molekulare Medizin Gmbh Wave1 inhibition in the medical intervention of inflammatory diseases and/or infections caused by a pathogen
WO2011131626A1 (en) 2010-04-19 2011-10-27 Medizinische Universität Innsbruck Tmem195 encodes for tetrahydrobiopterin-dependent alkylglycerol monooxygenase activity
US9446039B2 (en) 2012-08-27 2016-09-20 Cemm Forschungszentrum Für Molekulare Medizin Gmbh Aminoheteroaryl compounds as MTH1 inhibitors
ES2753386T3 (es) 2013-03-13 2020-04-08 Forma Therapeutics Inc Derivados de 2-hidroxi-1-{4-[(4-fenil)fenil]carbonil}piperazin-1-il}etano-1-ona y compuestos relacionados como inhibidores de sintasa de ácido graso (FASN) para el tratamiento del cáncer
CN105044330B (zh) * 2015-08-28 2017-12-22 宁波瑞源生物科技有限公司 一种减少体外检测中生物样本假阳性的封闭液及其应用
CN106778032B (zh) * 2016-12-14 2019-06-04 南京邮电大学 药物设计中配体分子海量特征筛选方法
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
US10793554B2 (en) 2018-10-29 2020-10-06 Forma Therapeutics, Inc. Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7457796A (en) * 1995-10-23 1997-05-15 Tularik Inc. Rip: novel human protein involved in tumor necrosis factor signal transduction, and screening assays
WO1997031646A1 (en) * 1996-02-28 1997-09-04 University Of Colorado Steroid receptor antagonist co-modulator and methods for using same

Also Published As

Publication number Publication date
EP1073891B1 (de) 2006-08-09
KR20010042966A (ko) 2001-05-25
WO1999054728A3 (en) 2000-02-10
CA2329738A1 (en) 1999-10-28
AU769917B2 (en) 2004-02-12
EP1073891A2 (de) 2001-02-07
JP2002512368A (ja) 2002-04-23
CA2329738C (en) 2008-10-07
IL139163A0 (en) 2001-11-25
AU3209199A (en) 1999-11-08
WO1999054728A2 (en) 1999-10-28
ATE335994T1 (de) 2006-09-15
DE69932712D1 (de) 2006-09-21
KR100637955B1 (ko) 2006-10-23
DE69932712T2 (de) 2007-09-06

Similar Documents

Publication Publication Date Title
IL139163A0 (en) A method of predicting the ability of compounds to modulate the biological activity of receptors
Kauvar et al. Predicting ligand binding to proteins by affinity fingerprinting
EP1028315A3 (de) Zielspezifische Screens und ihre Verwendung zur Ermittelung von kleinen organischen molekularen Pharmakophoren
BR9815059A (pt) triagem de alta produtividade em formato contìnuo
CA2251842A1 (en) Small molecule mimetics of erythropoietin
ATE291583T1 (de) Polymorphismus von mononukleotiden und ihre verwendung in der genanalyse
GB2318580B (en) Microspheres with fluorescent spherical zones
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
AU4829999A (en) Methods for rapidly identifying small organic ligands
WO2005010215A3 (en) Methods for identifying tolerance modulatory compounds and uses therefor
DE69936312D1 (de) Mutanten von op-1
ATE529509T1 (de) Selektion von proteinen unter verwendung von rna- protein-fusionen
ATE153707T1 (de) Diagnostische anwendungen der bildung von doppelten d-loops.
DE69826240D1 (de) Diagnosesystem
DE59814441D1 (de) Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren
DE69018117D1 (de) Zur Synthese von Karotinoiden verwendbare DNA-Sequenzen.
AU2023499A (en) Pth receptor and screening assay utilizing the same
DE69828080D1 (de) Pyrimidinderivate als markierte bindungspartner
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
DE69731964D1 (de) Map-kinase: polypeptide, polynukleotide und ihre verwendung
DE69728897D1 (de) Saeugetierchemokine
CA2273855A1 (en) Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof
ZA962813B (en) Polypeptides having a functional domain of interest and method of identifying and using same
DE69734199D1 (de) Menschliches netrin-1
EP1042349A4 (de) Verwendung von an polyamid gebundene nukleinsäure-oligomere zur erzeugung einer biologischen reaktion

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees